Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxoprofen Pain Patch for DOMS
NCT02602353Phase 2Completed
- Sponsor
- Lead Chemical
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of loxoprofen in delayed onset muscle soreness (DOMS), sponsored by Lead Chemical. Started Oct 2015; status: completed.
02
Drugs
loxoprofen
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT02602353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602353.